Published in Can J Cardiol on September 17, 2010
The 'all comer' Coroflex Please drug-eluting stent registry in Europe and Asia - an overall and transcontinental assessment of the 10-month major adverse cardiac events. Indian Heart J (2012) 0.78
Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2016) 0.75
Impact of coexisting multivessel coronary artery disease on short-term outcomes and long-term survival of patients treated with carotid stenting. Arch Med Sci (2016) 0.75
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med (2004) 11.86
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med (1994) 9.15
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med (2005) 6.53
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med (2007) 4.95
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J (2006) 4.38
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med (2002) 4.25
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet (1998) 4.03
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med (1994) 3.96
Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med (2007) 2.50
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation (2003) 2.31
Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation (2006) 2.18
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation (2007) 1.85
Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol (1997) 1.84
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation (2004) 1.83
Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents. Circulation (2008) 1.77
Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation (2008) 1.68
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation (2005) 1.38
The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol (2005) 1.21
Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol (2001) 1.15
The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial. J Am Coll Cardiol (2005) 1.07
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol (2001) 1.03
Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention. Am J Cardiol (2008) 0.81
Percutaneous coronary implantation of sirolimus-eluting stents in unselected patients and lesions: clinical results and multiple outcome predictors. Am Heart J (2008) 0.78
Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc Surg (2003) 3.17
Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg (2005) 2.91
Impact of delays to cardiac surgery after failed angioplasty and stenting. J Am Coll Cardiol (2004) 2.81
Mitral valve surgery in patients with extensive calcification of the mitral annulus. J Thorac Cardiovasc Surg (2003) 2.71
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation (2012) 2.08
Left ventricular reconstruction: Early and late results. J Thorac Cardiovasc Surg (2004) 2.06
Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis. J Thorac Cardiovasc Surg (2004) 2.03
A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Am J Clin Nutr (2010) 1.79
Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg (2004) 1.75
Clinical outcomes after separate and composite replacement of the aortic valve and ascending aorta. J Thorac Cardiovasc Surg (2004) 1.71
Late outcomes of mitral valve repair for floppy valves: Implications for asymptomatic patients. J Thorac Cardiovasc Surg (2003) 1.69
Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. J Am Coll Cardiol (2011) 1.65
An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med (2003) 1.65
A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J Thorac Cardiovasc Surg (2005) 1.61
Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: a 25-year experience. J Thorac Cardiovasc Surg (2012) 1.54
The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg (2002) 1.48
Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation (2008) 1.47
Long-term outcomes using a two-stent technique for the treatment of coronary bifurcations. Int J Cardiol (2012) 1.47
In-hospital outcomes of very elderly patients (85 years and older) undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv (2011) 1.44
Cardiac-specific sympathetic activation in men and women with and without heart failure. Heart (2010) 1.41
Activity with ambulation attenuates diuretic responsiveness in chronic heart failure. J Card Fail (2011) 1.39
Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up. Catheter Cardiovasc Interv (2011) 1.39
Balloon crush: treatment of bifurcation lesions using the crush stenting technique as adapted for transradial approach of percutaneous coronary intervention. Catheter Cardiovasc Interv (2004) 1.38
Aortic valve-sparing operations in patients with aneurysms of the aortic root or ascending aorta. Ann Thorac Surg (2002) 1.14
Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation. Can J Cardiol (2012) 1.14
Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation (2005) 1.11
Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant (2009) 1.09
Stentless aortic valves are hemodynamically superior to stented valves during mid-term follow-up: a large retrospective study. Ann Thorac Surg (2005) 1.08
Radial artery patency after transradial catheterization. Circ Cardiovasc Interv (2012) 1.06
The Toronto score for in-hospital mortality after percutaneous coronary interventions. Am Heart J (2009) 1.04
Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: an analysis of clinical outcomes. J Thorac Cardiovasc Surg (2005) 1.03
The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Circ Cardiovasc Interv (2009) 0.99
Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology (2006) 0.99
Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg (2002) 0.98
A 17-month evaluation of a chlorine dioxide water treatment system to control Legionella species in a hospital water supply. Infect Control Hosp Epidemiol (2003) 0.96
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction. Circulation (2011) 0.96
Sex-specific long-term outcomes after combined valve and coronary artery surgery. Ann Thorac Surg (2006) 0.95
Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure. J Heart Lung Transplant (2008) 0.95
Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis (2006) 0.95
Mild to moderate mitral regurgitation in patients undergoing coronary bypass grafting: effects on operative mortality and long-term significance. Ann Thorac Surg (2003) 0.94
Ventricular reconstruction for ischemic cardiomyopathy. Ann Thorac Surg (2003) 0.94
Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle. Am Heart J (2006) 0.94
Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Genet (2012) 0.93
Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J (2006) 0.92
Mitral annular disjunction in advanced myxomatous mitral valve disease: echocardiographic detection and surgical correction. J Am Soc Echocardiogr (2005) 0.90
Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves? J Thorac Cardiovasc Surg (2003) 0.90
Nutritional inadequacies in patients with stable heart failure. J Am Diet Assoc (2009) 0.89
Aortic valve repair versus replacement in bicuspid aortic valve disease. J Heart Valve Dis (2003) 0.88
Gender differences in quality of distal vessels: effect on results of coronary artery bypass grafting. J Thorac Cardiovasc Surg (2003) 0.86
Aortic root replacement in patients with previous heart surgery. J Card Surg (2004) 0.85
Evaluating surrogate measures of renal dysfunction after cardiac surgery. Anesth Analg (2003) 0.85
Relationship of bipolar and unipolar electrogram voltage to scar transmurality and composition derived by magnetic resonance imaging in patients with nonischemic cardiomyopathy undergoing VT ablation. Heart Rhythm (2012) 0.85
Short-term memory and restitution during ventricular fibrillation in human hearts: an in vivo study. Circ Arrhythm Electrophysiol (2009) 0.84
Temporal trends in cardiogenic shock treatment and outcomes among ontario patients with myocardial infarction between 1992 and 2008. Circ Cardiovasc Qual Outcomes (2011) 0.84
Quantification of mitral valve anatomy by three-dimensional transesophageal echocardiography in mitral valve prolapse predicts surgical anatomy and the complexity of mitral valve repair. J Am Soc Echocardiogr (2012) 0.83
Selective use of embolic protection devices during saphenous vein grafts interventions: a single-center experience. Catheter Cardiovasc Interv (2010) 0.83
Predictors of acute renal dysfunction after ventricular assist device placement. J Card Fail (2009) 0.83
Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes. Catheter Cardiovasc Interv (2010) 0.83
The Canadian Association of Interventional Cardiology and the Canadian Cardiovascular Society joint statement on drug-eluting stents. Can J Cardiol (2007) 0.83
Increasing mortality burden among adults with complex congenital heart disease. Congenit Heart Dis (2014) 0.83
Muscle sympathetic nerve activity and ventilation during exercise in subjects with and without chronic heart failure. Can J Cardiol (2008) 0.82
Gender-related differences in morbidity and mortality during combined valve and coronary surgery. J Thorac Cardiovasc Surg (2003) 0.82
Dysphagia and associated risk factors following extubation in cardiovascular surgical patients. Dysphagia (2014) 0.81
Distribution and determinants of myocardial perfusion grade following late mechanical recanalization of occluded infarct-related arteries postmyocardial infarction: a report from the occluded artery trial. Catheter Cardiovasc Interv (2008) 0.81
Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention. Am J Cardiol (2008) 0.81
Sex differences in depression after coronary artery bypass graft surgery. Am Heart J (2005) 0.81
Sex differences in the management and outcomes of Ontario patients with cardiogenic shock complicating acute myocardial infarction. Can J Cardiol (2012) 0.80
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. Circulation (2010) 0.80
Long-term outcomes after percutaneous coronary intervention of bifurcation narrowings. Am J Cardiol (2008) 0.80
A meta-analysis that misses the mark. J Am Coll Cardiol (2008) 0.79
Decreasing mortality for coronary artery bypass surgery in octogenarians. Can J Cardiol (2009) 0.79
Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability. J Thorac Cardiovasc Surg (2007) 0.79
A calcified neointima--"stent" within a stent. J Invasive Cardiol (2009) 0.78
Valve surgery in octogenarians: a safe option with good medium-term results. J Heart Valve Dis (2006) 0.78
An international survey of clinical practice during primary percutaneous coronary intervention for ST-elevation myocardial infarction with a focus on aspiration thrombectomy. EuroIntervention (2013) 0.78
Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function. Eur J Cardiothorac Surg (2006) 0.76
Modulated dispersion of activation and repolarization by premature beats in patients with cardiomyopathy at risk of sudden death. Am J Physiol Heart Circ Physiol (2011) 0.76
First Canadian experience with high-risk percutaneous coronary intervention with assistance of a percutaneously deployed left ventricular assist device. Can J Cardiol (2008) 0.76
Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention. Am Heart J (2008) 0.76
Latent microvolt T-wave alternans in survivors of unexplained cardiac arrest unmasked by epinephrine challenge. Heart Rhythm (2012) 0.75
N-terminal-pro-B-type natriuretic peptide in cardiogenic shock: a marker ready for prime time or a therapeutic target? Crit Care Med (2009) 0.75